Alnylam Pharmaceuticals (ALNY) Depreciation & Amortization (CF) (2009 - 2026)
Alnylam Pharmaceuticals (ALNY) posted Depreciation & Amortization (CF) of $13.9 million for Q2 2026, down 0.3% from $13.94 million a year earlier but up 2.6% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Alnylam Pharmaceuticals was $54.76 million, down 3.1% year-over-year; for FY2025, it was $55.66 million, down 1.8% from FY2024.
- Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 9.9% (FY2020 to FY2025).
- In prior years, Alnylam Pharmaceuticals' Depreciation & Amortization (CF) was $56.67 million in FY2024 (+4.8%), $54.05 million in FY2023 (+21.6%), $44.47 million in FY2022 (-6.5%) and $47.57 million in FY2021 (+36.8%).
- Quarterly Depreciation & Amortization (CF) has run from a low of $9.46 million in Q1 2022 to a high of $15 million in Q2 2024 over five years.
- On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last five quarters, with an average decline of 0.3% over the last eight quarters.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q1 2023, with growth of 48.7%; the weakest was Q1 2022, with a decline of 24.9%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $13.55 million (Q1 2026), $13.51 million (Q4 2025) and $13.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn | 13.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.90 Mn |
| Mar 31, 2026 | 13.55 Mn |
| Dec 31, 2025 | 13.51 Mn |
| Sep 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 13.94 Mn |
| Mar 31, 2025 | 14.41 Mn |
| Dec 31, 2024 | 14.17 Mn |
| Sep 30, 2024 | 13.98 Mn |
| Jun 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 13.52 Mn |
| Dec 31, 2023 | 13.48 Mn |
| Sep 30, 2023 | 13.33 Mn |
| Jun 30, 2023 | 13.18 Mn |
| Mar 31, 2023 | 14.07 Mn |
| Dec 31, 2022 | 14.31 Mn |
| Sep 30, 2022 | 10.60 Mn |
| Jun 30, 2022 | 10.10 Mn |
| Mar 31, 2022 | 9.46 Mn |
| Dec 31, 2021 | 11.38 Mn |
| Sep 30, 2021 | 11.79 Mn |
API Access
Alnylam Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();